phase 2_completion
saveAlentis Therapeutics AG — lixudebart (Phase II Trial Completion)
community read0 votes
Therapy area: Genito Urinary System, Immunology. Indication: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis), Glomerulonephritis, Kidney Fibrosis